Recently, Huaxia Ophthalmology opened its application with an issue price of 50.
88 yuan per share, and is expected to land on the Growth Enterprise Market of
the Shenzhen Stock Exchange in early November.
The total amount raised this time reached 3.
052 billion yuan, which was about
3 times overfunded.
Based on the total share capital after the issuance, the total market value of Huasha Ophthalmology is about 28.
49 billion yuan
.
It is understood that as early as 2016, Huaxia Ophthalmology launched listing counseling, and in 2020, Huaxia Ophthalmology officially opened its public prospectus to move towards
the capital market.
One year later, it was approved by the GEM Listing Committee meeting
.
After five years, Huaxia Ophthalmology finally crossed the threshold
of listing.
According to public information, the main business of Huaxia Ophthalmology is ophthalmic specialist medical services
.
At present, the company has established eight ophthalmic subspecialty departments covering cataracts, fundus, refraction, oblique amblyopia and pediatric ophthalmology, ocular surface, glaucoma, orbit and eye tumors, and eye trauma, as well as an ophthalmic general practice diagnosis and treatment service system
.
At present, more and more ophthalmology-related companies are trying to knock on the door
of the capital market.
Since the beginning of this year, in addition to Huaxia Ophthalmology, He's Ophthalmology and Puri Ophthalmology have also landed on the A-share market
one after another.
On March 22, He's Ophthalmology was listed on the Growth Enterprise Market of the Shenzhen Stock Exchange, making it the second A-share eye hospital
after Aier Ophthalmology.
From the performance of the capital market, as of the opening of the day, He's Ophthalmology closed at 49.
5 yuan, up 16.
47% from the issue price of 42.
5 yuan, with a total market value of 6.
017 billion yuan
.
Listed on the Growth Enterprise Market of the Shenzhen Stock Exchange on July 5 this year, as a chain ophthalmic brand, the company has been adopting the "direct chain" business model since its establishment
.
As of September 23, Preh Ophthalmology replied to investors that the company has opened 23 chain ophthalmic specialty hospitals and three eye clinics, covering all municipalities directly under the central government and more than ten provincial capitals
.
Among them, in the first half of this year, Kunming Runcheng Second Hospital, Hefei Yaohai Second Hospital, Nanchang Honggutan Second Hospital and Guangzhou Panyu Purui opened
one after another.
Now, Huaxia Ophthalmology is also about to realize its dream of IPO
.
Industry analysts believe that in view of the fact that Huaxia Ophthalmology has a certain market position in the industry and the overall market sentiment of the medical sector is good in the near future, the market may be able to give a certain premium space
in the short term.
In fact, many companies accelerate IPOs mainly because they are optimistic about the development of the ophthalmic track and want to accelerate the layout
.
As a myopic country, ophthalmology has always belonged to the high-prosperity track
.
According to Frost & Sullivan, the overall size of China's ophthalmic market reached 170 billion yuan in 2019, of which the ophthalmic medical market was 124 billion, accounting for 73%; the ophthalmic device market was 26.
7 billion yuan, accounting for 16%; The ophthalmic drug market was 19.
3 billion yuan, accounting for 11%.
In general, the ophthalmic medical service market undoubtedly has huge market prospects, and a large number of companies are currently accelerating the layout of this field
.
In addition to the listed Aier Ophthalmology, Guangzheng Ophthalmology, Chaoju Ophthalmology, Xima Ophthalmology, etc.
, there are still many companies that are still impacting IPOs
.
The industry expects that in the future, related enterprises will face more and more fierce market competition
while gaining more opportunities for promotion.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"Share to:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
